Gene · 7329
Papers3,237
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,237
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigating SARS-CoV-2 virus-host interactions and mRNA expression: Insights using three models of D. melanogaster. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38925484 | PubTator, text mining | PubMed |
| Establishment of a SUMO pathway related gene signature for predicting prognosis, chemotherapy response and investigating the role of EGR2 in bladder cancer. | J Cancer | 2024 | 38911380 | PubTator, text mining | PubMed |
| Rhes, a striatal enriched protein, regulates post-translational small-ubiquitin-like-modifier (SUMO) modification of nuclear proteins and alters gene expression. | Cell Mol Life Sci | 2024 | 38589732 | PubTator, text mining | PubMed |
| SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer. | Cell Rep | 2024 | 38507413 | PubTator, text mining | PubMed |
| NFATC2IP is a mediator of SUMO-dependent genome integrity. | Genes Dev | 2024 | 38503515 | PubTator, text mining | PubMed |
| Repression of the SUMO-conjugating enzyme UBC9 is associated with lowered double minutes and reduced tumor progression. | Cancer Biol Ther | 2024 | 38465861 | PubTator, text mining | PubMed |
| Porcine circovirus type 2 infection promotes the SUMOylation of nucleophosmin-1 to facilitate the viral circular single-stranded DNA replication. | PLoS Pathog | 2024 | 38394330 | PubTator, text mining | PubMed |
| UBC9-mediated SUMOylation of Lamin B1 enhances DNA-damage-induced nuclear DNA leakage and autophagy after spinal cord injury. | J Cell Physiol | 2024 | 38308641 | PubTator, text mining | PubMed |
| Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells. | J Biomed Sci | 2024 | 38280996 | PubTator, text mining | PubMed |
| Hypoxia-driven deSUMOylation of EXOSC10 promotes adaptive changes in the transcriptome profile. | Cell Mol Life Sci | 2024 | 38279024 | PubTator, text mining | PubMed |
| UBR5 promotes antiviral immunity by disengaging the transcriptional brake on RIG-I like receptors. | Nat Commun | 2024 | 38278841 | PubTator, text mining | PubMed |
| Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications. | Cells | 2024 | 38275816 | PubTator, text mining | PubMed |
| Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate. | Biomolecules | 2024 | 38275765 | PubTator, text mining | PubMed |
| Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD. | Mol Neurodegener | 2024 | 38254150 | PubTator, text mining | PubMed |
| The Multifaceted Roles of NRF2 in Cancer: Friend or Foe? | Antioxidants (Basel) | 2024 | 38247494 | PubTator, text mining | PubMed |
| SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells. | Cell Mol Biol Lett | 2024 | 38229033 | PubTator, text mining | PubMed |
| A SUMO E3 ligase promotes long non-coding RNA transcription to regulate small RNA-directed DNA elimination. | Elife | 2024 | 38197489 | PubTator, text mining | PubMed |
| Sumoylation of SAP130 regulates its interaction with FAF1 as well as its protein stability and transcriptional repressor function. | BMC Mol Cell Biol | 2024 | 38172660 | PubTator, text mining | PubMed |
| TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | Nat Commun | 2024 | 38172120 | PubTator, text mining | PubMed |
| Stabilization of Pin1 by USP34 promotes Ubc9 isomerization and protein sumoylation in glioma stem cells. | Nat Commun | 2024 | 38167292 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7329/papers?page=6